{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:58:25Z","timestamp":1791575905420,"version":"4.3.4"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007329","name":"University of the Valley","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate cancer is a significant global health concern and one of the leading causes of death from diseases in men. There is a growing interest in exploring new therapeutic approaches to enhance patient treatment outcomes and quality of life. Snake venom-derived compounds have emerged as promising candidates for anticancer treatment due to their potential to be selective and reduce adverse effects. In this article, we conduct a literature review on prostate cancer and discuss the investigation of snake venoms as potential alternatives in treatments to minimize toxicity and maximize efficacy. The potential of snake venom toxins in modulating key processes such as cell apoptosis, inhibition of cell migration, and angiogenesis is highlighted. This comprehensive exploration reaffirms the importance of advancing research into snake venom-based therapies to combat prostate cancer, transform treatment paradigms, and improve the well-being of affected individuals.<\/jats:p>","DOI":"10.1007\/s11033-024-09970-z","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:24:40Z","timestamp":1731587080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Snake venom toxins as potential therapeutic agents in the treatment of prostate cancer"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6268-6833","authenticated-orcid":false,"given":"Jesika","family":"Ochoa-Mosquera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-4207","authenticated-orcid":false,"given":"Alejandro","family":"Montoya-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6043-1521","authenticated-orcid":false,"given":"Eli\u00e9cer","family":"Jim\u00e9nez\u2011Charris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"3","key":"9970_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"9970_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"9970_CR3","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2024) Global Cancer Observatory: C\u00e1ncer Tomorrow. Lyon, Francia: International Agency for Research on Cancer. https:\/\/gco.iarc.fr\/tomorrow\/en Accessed 9 March 2024"},{"key":"9970_CR4","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2024) Global Cancer Observatory: Colombia. Lyon, Francia: International Agency for Research on Cancer. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/170-colombia-fact-sheet.pdf Accessed 9 March 2024"},{"key":"9970_CR5","unstructured":"American Cancer Society (2024) Tratamiento del c\u00e1ncer de pr\u00f3stata. https:\/\/www.cancer.org\/es\/cancer\/tipos\/cancer-de-prostata\/tratamiento.html Accessed 2 August 2024"},{"issue":"1","key":"9970_CR6","first-page":"26","volume":"88","author":"D Barreiro","year":"2023","unstructured":"Barreiro D, Castro F, Castro P et al (2023) Gu\u00eda para El diagn\u00f3stico Y tratamiento del c\u00e1ncer de pr\u00f3stata. Rev Argent Urol 88(1):26\u201344","journal-title":"Rev Argent Urol"},{"key":"9970_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.semcancer.2020.05.006","volume":"80","author":"FA Urra","year":"2022","unstructured":"Urra FA, Araya-Maturana R (2022) Putting the brakes on tumorigenesis with snake venom toxins: new molecular insights for cancer drug discovery. Semin Cancer Biol 80:195\u2013204. https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.006","journal-title":"Semin Cancer Biol"},{"issue":"58","key":"9970_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/B978-012369442-3\/50061-1","volume":"2","author":"C Beeton","year":"2006","unstructured":"Beeton C, Gutman GA, Chandy G (2006) Targets and therapeutic properties of venom peptides. Handb Biologically Act Peptides 2(58):403\u2013413. https:\/\/doi.org\/10.1016\/B978-012369442-3\/50061-1","journal-title":"Handb Biologically Act Peptides"},{"issue":"24","key":"9970_CR9","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s00018-006-6315-0","volume":"63","author":"D Koh","year":"2006","unstructured":"Koh D, Armugam A, Jeyaseelan K (2006) Snake venom components and their applications in biomedicine. Cell Mol Life Sci 63(24):3030\u20133041. https:\/\/doi.org\/10.1007\/s00018-006-6315-0","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"9970_CR10","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.bmc.2017.09.029","volume":"26","author":"MW Pennington","year":"2018","unstructured":"Pennington MW, Czerwinski A, Norton RS (2018) Peptide therapeutics from venom: current status and potential. Bioorg Med Chem 26(10):2738\u20132758. https:\/\/doi.org\/10.1016\/j.bmc.2017.09.029","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"9970_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/toxins10090346","volume":"10","author":"L Li","year":"2018","unstructured":"Li L, Huang J, Lin Y (2018) Snake venoms in cancer therapy: past, present and future. Toxins 10(9):346. https:\/\/doi.org\/10.3390\/toxins10090346","journal-title":"Toxins"},{"key":"9970_CR12","unstructured":"Nosti A (2019) Venenos de serpiente, no tan malos como los pintan. Undergraduate Dissertation, Universidad de Sevilla"},{"issue":"9","key":"9970_CR13","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.biocel.2013.06.009","volume":"45","author":"C Marcinkiewicz","year":"2013","unstructured":"Marcinkiewicz C (2013) Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem 45(9):1974\u20131986. https:\/\/doi.org\/10.1016\/j.biocel.2013.06.009","journal-title":"Int J Biochem"},{"issue":"1","key":"9970_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van der Kwast T, Bristow RG (2021) Prostate cancer. Nat Rev Dis Primers 7(1):9. https:\/\/doi.org\/10.1038\/s41572-020-00243-0","journal-title":"Nat Rev Dis Primers"},{"key":"9970_CR15","unstructured":"Cata\u00f1o-Cata\u00f1o JG, Castillo-Londo\u00f1o JS, Gamboa-Garay OA, Aponte-Var\u00f3n H, Alvarado-Bestene R, Cort\u00e9s-Buitrago C (2013) Instituto Nacional de Cancerolog\u00eda. Gu\u00eda de pr\u00e1ctica cl\u00ednica (GPC) para la detecci\u00f3n temprana, seguimiento y rehabilitaci\u00f3n del c\u00e1ncer de pr\u00f3stata. 717:34\u201383"},{"issue":"2","key":"9970_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, Yegnasubramanian S (2021) Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol 18(2):79\u201392. https:\/\/doi.org\/10.1038\/s41585-020-00400-w","journal-title":"Nat Rev Urol"},{"issue":"12","key":"9970_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31434\/rms.v8i12.1124","volume":"8","author":"VN Yanes-Alison","year":"2023","unstructured":"Yanes-Alison VN, Cubas S (2023) C\u00e1ncer De pr\u00f3stata: una perspectiva global. Rev Med Sinerg 8(12):1\u201312. https:\/\/doi.org\/10.31434\/rms.v8i12.1124","journal-title":"Rev Med Sinerg"},{"key":"9970_CR18","unstructured":"National Cancer Institute (2023) Prostate Cancer Treatment (PDQ\u00ae)\u2013Patient Version. https:\/\/www.cancer.gov\/types\/prostate\/patient\/prostate-treatment-pdq Accessed 13 March 2024"},{"issue":"5","key":"9970_CR19","doi-asserted-by":"publisher","first-page":"10438","DOI":"10.3390\/ijms140510438","volume":"14","author":"S Muniyan","year":"2013","unstructured":"Muniyan S, Chaturvedi NK, Dwyer JG, Lagrange CA, Chaney WG, Lin MF (2013) Human prostatic acid phosphatase: structure, function and regulation. Int J Mol Sci 14(5):10438\u201310464. https:\/\/doi.org\/10.3390\/ijms140510438","journal-title":"Int J Mol Sci"},{"key":"9970_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/pros.20188","volume":"63","author":"LN Thomas","year":"2005","unstructured":"Thomas LN, Lazier CB, Gupta R, Norman RW, Troyer DA, O\u2019brien SP, Rittmaster RS (2005) Differential alterations in 5a-Reductase type 1 and type 2 levels during development and progression of prostate Cancer. Prostate 63:231\u2013239. https:\/\/doi.org\/10.1002\/pros.20188","journal-title":"Prostate"},{"issue":"4","key":"9970_CR21","first-page":"250","volume":"68","author":"A Blanco","year":"2008","unstructured":"Blanco A, Escudero de los R\u00edos PM, Hern\u00e1ndez Tor\u00edz N (2008) C\u00e1ncer De pr\u00f3stata. Rev Mex Urol 68(4):250\u2013259","journal-title":"Rev Mex Urol"},{"key":"9970_CR22","doi-asserted-by":"publisher","unstructured":"Pesce G (2011) Cellular interactions that regulate prostate cancer growth, survival and tumourigenicity. Doctoral Dissertation, University of Sheffield. https:\/\/doi.org\/10.13140\/RG.2.2.26238.54088","DOI":"10.13140\/RG.2.2.26238.54088"},{"issue":"1","key":"9970_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.juro.2009.08.104","volume":"183","author":"WJ Aronson","year":"2010","unstructured":"Aronson WJ, Barnard RJ, Freedland SJ, Henning S, Elashoff D, Jardack PM, Cohen P, Heber D, Kobayashi N (2010) Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol 183(1):345\u2013350. https:\/\/doi.org\/10.1016\/j.juro.2009.08.104","journal-title":"J Urol"},{"issue":"17","key":"9970_CR24","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S (2022) Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches. Molecules 27(17):5730. https:\/\/doi.org\/10.3390\/molecules27175730","journal-title":"Molecules"},{"issue":"3","key":"9970_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.25176\/RFMH.v22i3.5043","volume":"22","author":"M Castro-Mujica","year":"2022","unstructured":"Castro-Mujica M (2022) Clinical implications of the molecular biology of prostate c\u00e1ncer: review article. Rev Fac Med Hum 22(3):597\u2013613. https:\/\/doi.org\/10.25176\/RFMH.v22i3.5043","journal-title":"Rev Fac Med Hum"},{"issue":"41","key":"9970_CR26","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.18632\/oncotarget.3925","volume":"10","author":"J Steinestel","year":"2019","unstructured":"Steinestel J, Luedeke M, Arndt A, Schnoeller TJ, Lennerz JK, Wurm C, Maier C, Cronauer MV, Steinestel K, Schrader AJ (2019) Detecting predictive androgen receptor modifications in circulating prostate cancer cells. Oncotarget 10(41):4213\u20134223. https:\/\/doi.org\/10.18632\/oncotarget.3925","journal-title":"Oncotarget"},{"issue":"10","key":"9970_CR27","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/ERC-22-0140","volume":"29","author":"M Shiota","year":"2022","unstructured":"Shiota M, Akamatsu S, Tsukahara S, Nagakawa S, Matsumoto T, Eto M (2022) Androgen receptor mutations for precision medicine in prostate cancer. Endocr Relat Cancer 29(10):R143\u2013R155. https:\/\/doi.org\/10.1530\/ERC-22-0140","journal-title":"Endocr Relat Cancer"},{"key":"9970_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring D, DePinho R (2018) Genetics and biology of prostate cancer. Genes Dev 32:1105\u20131140. https:\/\/doi.org\/10.1101\/gad.315739.118","journal-title":"Genes Dev"},{"issue":"11","key":"9970_CR29","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/nejmoa1315815","volume":"371","author":"ES Antonarakis","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC et al (2014) AR-V7 and Resistance to Enzalutamide and Abiraterone in prostate Cancer. N Engl J Med 371(11):1028\u20131038. https:\/\/doi.org\/10.1056\/nejmoa1315815","journal-title":"N Engl J Med"},{"issue":"2","key":"9970_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.22037\/uj.v4i2.138","volume":"4","author":"P Gholamreza","year":"2007","unstructured":"Gholamreza P, Abed-Ali Z, Amir A, Abdolrasoul M, Hossein A, Ali A, Hamid S (2007) Role of PTEN Gene in progression of prostate Cancer. Urol J 4(2):95\u2013100. https:\/\/doi.org\/10.22037\/uj.v4i2.138","journal-title":"Urol J"},{"key":"9970_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrurol.2018.9","volume":"15","author":"T Jamaspishvili","year":"2018","unstructured":"Jamaspishvili T, Berman D, Ross A, Scher H, De Marzo A, Squire J, Lotan T (2018) Clinical implications of PTEN loss in prostate cancer. Nat Rev Urol 15:222\u2013234. https:\/\/doi.org\/10.1038\/nrurol.2018.9","journal-title":"Nat Rev Urol"},{"issue":"15","key":"9970_CR32","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/cncr.31316","volume":"124","author":"J Zhen","year":"2018","unstructured":"Zhen J, Syed J, Anh K, Leapman M, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B (2018) Genetic testing for heredetary prostate c\u00e1ncer: current status and limitations. Cancer 124(15):3105\u20133117. https:\/\/doi.org\/10.1002\/cncr.31316","journal-title":"Cancer"},{"issue":"7","key":"9970_CR33","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3390\/ijms22073753","volume":"22","author":"M Vietri","year":"2021","unstructured":"Vietri M, D\u2019elia G, Caliendo G, Resse M, Casamassimi A, Passariello L, Albanese L, Cioffi M, Molinari A (2021) Hereditary prostate Cancer: genes related, Target Therapy and Prevention. Int J Mol Sci 22(7):3753. https:\/\/doi.org\/10.3390\/ijms22073753","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9970_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.gendis.2017.01.003","volume":"4","author":"H Brechka","year":"2017","unstructured":"Brechka H, Bhanvadia R, VanOpstall C, Vander D (2017) HOXB13 mutations and binding partners in prostate development and cancer: function, clinical significance, and future directions. Genes Dis 4(2):75\u201387. https:\/\/doi.org\/10.1016\/j.gendis.2017.01.003","journal-title":"Genes Dis"},{"issue":"9","key":"9970_CR35","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.19230\/jonnpr.3686","volume":"5","author":"L\u00c1 Islas-P\u00e9rez","year":"2020","unstructured":"Islas-P\u00e9rez L\u00c1, Mart\u00ednez-Res\u00e9ndiz JI, Ruiz-Hern\u00e1ndez et al (2020) Epidemiolog\u00eda Del c\u00e1ncer De pr\u00f3stata, sus determinantes y prevenci\u00f3n. J Negat No Posit Results 5(9):1010\u20131022. https:\/\/doi.org\/10.19230\/jonnpr.3686","journal-title":"J Negat No Posit Results"},{"issue":"2","key":"9970_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate Cancer. World J Oncol 10(2):63\u201389. https:\/\/doi.org\/10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"9970_CR37","doi-asserted-by":"publisher","first-page":"811044","DOI":"10.3389\/fpubh.2022.811044","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, Lu B, He M, Wang Y, Wang Z, Du L (2022) Prostate Cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health 10:811044. https:\/\/doi.org\/10.3389\/fpubh.2022.811044","journal-title":"Front Public Health"},{"issue":"1","key":"9970_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/21681805.2017.1411392","volume":"52","author":"J Hugosson","year":"2018","unstructured":"Hugosson J, Godtman RA, Carlsson SV, Aus G, Grenabo Bergdahl A, Lodding P et al (2018) Eighteen-year follow-up of the G\u00f6teborg Randomized Population-based prostate Cancer screening trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality. Scand J Urol 52(1):27\u201337. https:\/\/doi.org\/10.1080\/21681805.2017.1411392","journal-title":"Scand J Urol"},{"issue":"4","key":"9970_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ijc.2910150411","volume":"15","author":"B Armstrong","year":"1975","unstructured":"Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15(4):617\u2013631. https:\/\/doi.org\/10.1002\/ijc.2910150411","journal-title":"Int J Cancer"},{"issue":"8","key":"9970_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrurol.2010.102","volume":"7","author":"V Venkateswaran","year":"2010","unstructured":"Venkateswaran V, Klotz LH (2010) Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol 7(8):442\u2013453. https:\/\/doi.org\/10.1038\/nrurol.2010.102","journal-title":"Nat Rev Urol"},{"issue":"20","key":"9970_CR41","doi-asserted-by":"publisher","first-page":"19911","DOI":"10.1074\/jbc.M412443200","volume":"280","author":"SV Singh","year":"2005","unstructured":"Singh SV, Srivastava SK, Choi S, Lew KL et al (2005) Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 280(20):19911\u201319924. https:\/\/doi.org\/10.1074\/jbc.M412443200","journal-title":"J Biol Chem"},{"key":"9970_CR42","unstructured":"American Cancer Society (2019) Detecci\u00f3n temprana, diagnostico y clasificaci\u00f3n por etapas del c\u00e1ncer de pr\u00f3stata. https:\/\/www.cancer.org Accessed 12 April 2024"},{"issue":"3","key":"9970_CR43","first-page":"876","volume":"21","author":"AI Ruiz L\u00f3pez","year":"2017","unstructured":"Ruiz L\u00f3pez AI, P\u00e9rez Mesa JC, Cruz Batista Y, Gonz\u00e1lez Lorenzo LE (2017) Actualizaci\u00f3n sobre c\u00e1ncer de pr\u00f3stata. Correo Cient Med 21(3):876\u2013887","journal-title":"Correo Cient Med"},{"issue":"1","key":"9970_CR44","first-page":"42","volume":"19","author":"FSF Marichal","year":"2015","unstructured":"Marichal FSF, Garc\u00eda RT, \u00c1lvarez AV, Roque OS (2015) C\u00e1ncer prost\u00e1tico: correlaci\u00f3n entre El valor Del ant\u00edgeno prost\u00e1tico espec\u00edfico y El Resultado anatomocl\u00ednico. Rev Arch Med Camag\u00fcey 19(1):42\u201349","journal-title":"Rev Arch Med Camag\u00fcey"},{"issue":"1","key":"9970_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/aja.2008.19","volume":"11","author":"N Borley","year":"2009","unstructured":"Borley N, Feneley M (2009) Prostate cancer: diagnosis and staging. Asian J Androl 11(1):74\u201380. https:\/\/doi.org\/10.1038\/aja.2008.19","journal-title":"Asian J Androl"},{"issue":"5","key":"9970_CR46","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.urology.2009.03.001","volume":"73","author":"ED Crawford","year":"2009","unstructured":"Crawford ED (2009) Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 73(5):S4. https:\/\/doi.org\/10.1016\/j.urology.2009.03.001","journal-title":"Urology"},{"issue":"3","key":"9970_CR47","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.juro.2007.10.057","volume":"179","author":"M Yin","year":"2008","unstructured":"Yin M, Bastacky S, Chandran U, Becich MJ, Dhir R (2008) Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. J Urol 179(3):892\u2013895. https:\/\/doi.org\/10.1016\/j.juro.2007.10.057","journal-title":"J Urol"},{"key":"9970_CR48","doi-asserted-by":"publisher","unstructured":"Surasi DSS, Chapin B, Tang C, Ravizzini G, Bathala TK (2020) Imaging and management of prostate cancer. Semin Ultrasound CT MR 41(2):207\u2013221. https:\/\/doi.org\/10.1053\/j.sult.2020.02.001","DOI":"10.1053\/j.sult.2020.02.001"},{"key":"9970_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pros.2990210521","volume":"4","author":"FH SchrlSder","year":"1992","unstructured":"SchrlSder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK (1992) The TNM classification of prostate cancer. Prostate 4:129\u2013138","journal-title":"Prostate"},{"issue":"1","key":"9970_CR50","first-page":"237","volume":"34","author":"P Bola\u00f1os","year":"2017","unstructured":"Bola\u00f1os P, Chac\u00f3n C (2017) Escala patol\u00f3gica De Gleason para El c\u00e1ncer De pr\u00f3stata y sus modificaciones. Med Leg Costa Rica 34(1):237\u2013243","journal-title":"Med Leg Costa Rica"},{"issue":"2","key":"9970_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.21149\/spm.v58i2.7797","volume":"58","author":"RA Castillejos-Molina","year":"2016","unstructured":"Castillejos-Molina RA, Gabilondo-Navarro FB (2016) C\u00e1ncer De pr\u00f3stata. Salud Publ Mex 58(2):279\u2013284","journal-title":"Salud Publ Mex"},{"key":"9970_CR52","unstructured":"Ministerio de Salud de Chile (2015) Gu\u00eda Cl\u00ednica auge c\u00e1ncer de pr\u00f3stata en personas de 15 a\u00f1os y m\u00e1s. https:\/\/diprece.minsal.cl\/wrdprss_minsal\/wp-content\/uploads\/2016\/03\/Cancer-de_prostata_25-nov-2015.pdf Accessed 20 May 2024"},{"issue":"34","key":"9970_CR53","first-page":"4","volume":"4","author":"IJ Jim\u00e9nez","year":"2021","unstructured":"Jim\u00e9nez IJ (2021) Tratamiento Del C\u00e1ncer De Pr\u00f3stata localizado. NPunto 4(34):4\u201326","journal-title":"NPunto"},{"issue":"24","key":"9970_CR54","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1158\/0008-5472.CAN-18-0254","volume":"78","author":"W Jaratlerdsiri","year":"2018","unstructured":"Jaratlerdsiri W, Chan EK, Gong T, Petersen DC et al (2018) Whole-genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in African men with treatment-na\u00efve, high-risk prostate cancer. Cancer Res 78(24):6736\u20136746. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0254","journal-title":"Cancer Res"},{"issue":"7","key":"9970_CR55","doi-asserted-by":"publisher","first-page":"djv431","DOI":"10.1093\/jnci\/djv431","volume":"108","author":"Y Han","year":"2016","unstructured":"Han Y, Rand KA, Hazelett DJ, Ingles SA et al (2016) Prostate cancer susceptibility in men of African ancestry at 8q24. J Natl Cancer Inst 108(7):djv431. https:\/\/doi.org\/10.1093\/jnci\/djv431","journal-title":"J Natl Cancer Inst"},{"key":"9970_CR56","unstructured":"American Cancer Society (2024) Treating Prostate Cancer. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/treating.html Accessed 12 April 2024"},{"issue":"15","key":"9970_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0093-7754(01)90148-4","volume":"28","author":"KJ Pienta","year":"2001","unstructured":"Pienta KJ (2001) Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer. Semin Oncol 28(15):3\u20137. https:\/\/doi.org\/10.1016\/S0093-7754(01)90148-4","journal-title":"Semin Oncol"},{"issue":"4","key":"9970_CR58","doi-asserted-by":"publisher","first-page":"676","DOI":"10.20517\/cdr.2020.37","volume":"3","author":"Y Sekino","year":"2020","unstructured":"Sekino Y, Teishima J (2020) Molecular mechanisms of docetaxel resistance in prostate cancer. Cancer Drug Resist 3(4):676\u2013685. https:\/\/doi.org\/10.20517\/cdr.2020.37","journal-title":"Cancer Drug Resist"},{"issue":"3","key":"9970_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.medcli.2014.12.021","volume":"146","author":"J Morote","year":"2016","unstructured":"Morote J, Maldonado X, Morales-B\u00e1rrera R (2016) C\u00e1ncer De pr\u00f3stata. Med Clin 146(3):121\u2013127. https:\/\/doi.org\/10.1016\/j.medcli.2014.12.021","journal-title":"Med Clin"},{"key":"9970_CR60","unstructured":"American Cancer Society (2023) Tratamiento del c\u00e1ncer de pr\u00f3stata. https:\/\/www.cancer.org\/content\/dam\/CRC\/PDF\/Public\/9000.00.pdf Accessed 13 April 2024"},{"key":"9970_CR61","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.semcancer.2020.08.010","volume":"80","author":"R Ma","year":"2022","unstructured":"Ma R, Kwok HF (2022) New opportunities and challenges of venom-based and bacteria-derived molecules for anticancer targeted therapy. Semin Cancer Biol 80:356\u2013369. https:\/\/doi.org\/10.1016\/j.semcancer.2020.08.010","journal-title":"Semin Cancer Biol"},{"key":"9970_CR62","doi-asserted-by":"publisher","first-page":"105327","DOI":"10.1016\/j.phrs.2020.105327","volume":"164","author":"S Mirzaei","year":"2021","unstructured":"Mirzaei S, Fekri HS, Hashemi F, Hushmandi K et al (2021) Venom peptides in cancer therapy: an updated review on cellular and molecular aspects. Pharmacol Res 164:105327. https:\/\/doi.org\/10.1016\/j.phrs.2020.105327","journal-title":"Pharmacol Res"},{"key":"9970_CR63","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/jms.1242","volume":"42","author":"JJ Calvete","year":"2007","unstructured":"Calvete JJ, Juarez P, Sanz L (2007) Snake Venomics Strategy and applications. J Mass Spectrom 42:1405\u20131414. https:\/\/doi.org\/10.1002\/jms.1242","journal-title":"J Mass Spectrom"},{"key":"9970_CR64","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1007\/s11033-020-05503-6","volume":"47","author":"A Montoya-G\u00f3mez","year":"2020","unstructured":"Montoya-G\u00f3mez A, Montealegre-S\u00e1nchez L, Garc\u00eda-Perdomo H, Jim\u00e9nez-Charris E (2020) Cervical cancer and potential pharmacological treatment with snake venoms. Mol Biol Rep 47:4709\u20134721. https:\/\/doi.org\/10.1007\/s11033-020-05503-6","journal-title":"Mol Biol Rep"},{"key":"9970_CR65","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/s0041-0101(98)00126-360","volume":"36","author":"F Markland","year":"1998","unstructured":"Markland F (1998) Snake venoms and the hemostatic system. Toxicon 36:1749\u20131800. https:\/\/doi.org\/10.1016\/s0041-0101(98)00126-360","journal-title":"Toxicon"},{"key":"9970_CR66","doi-asserted-by":"publisher","first-page":"583587","DOI":"10.3389\/fmolb.2020.583587","volume":"7","author":"HP Chong","year":"2020","unstructured":"Chong HP, Tan KY, Tan CH (2020) Cytotoxicity of snake venoms and cytotoxins from two southeast Asian cobras (Naja sumatrana, Naja kaouthia): exploration of anticancer potential, selectivity, and cell death mechanism. Front Mol Biosci 7:583587. https:\/\/doi.org\/10.3389\/fmolb.2020.583587","journal-title":"Front Mol Biosci"},{"key":"9970_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.toxicon.2017.06.008","volume":"135","author":"A Nalbantsoy","year":"2017","unstructured":"Nalbantsoy A, Hempel BF, Petras D, Heiss P, G\u00f6\u00e7men B, I\u011fci N, Yildiz MZ, S\u00fcssmuth RD (2017) Combined venom profiling and cytotoxicity screening of the Radde\u2019s mountain viper (Montivipera raddei) and Mount Bulgar Viper (Montivipera bulgardaghica) with potent cytotoxicity against human A549 lung carcinoma cells. Toxicon 135:71\u201383. https:\/\/doi.org\/10.1016\/j.toxicon.2017.06.008","journal-title":"Toxicon"},{"key":"9970_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1678-9199-jvatitd-2020-0013","volume":"26","author":"CH Tan","year":"2020","unstructured":"Tan CH, Liew JL, Navanesan S, Sim KS, Tan NH, Tan KY (2020) Cytotoxic and anticancer properties of the Malaysian mangrove pit viper (Trimeresurus purpureomaculatus) venom and its disintegrin (purpureomaculin). J Venom Anim Toxins Incl Trop Dis 26:1\u201314. https:\/\/doi.org\/10.1590\/1678-9199-jvatitd-2020-0013","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"9970_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10616-013-9540-z","volume":"66","author":"HT Yalcin","year":"2014","unstructured":"Yalcin HT, Ozen MO, Gocmen B, Nalbantsoy A (2014) Effect of Ottoman viper (Montivipera xanthina (Gray, 1849)) venom on various Cancer cells and on microorganisms. Cytotechnology 66:87\u201394. https:\/\/doi.org\/10.1007\/s10616-013-9540-z","journal-title":"Cytotechnology"},{"key":"9970_CR70","doi-asserted-by":"publisher","unstructured":"Omran MAA (2002) In vitro anticancer effect of scorpion Leiurus quinquestriatus and Egyptian cobra venom on human breast and prostate cancer cell lines. J Med Sci 3(1):66\u201386. https:\/\/doi.org\/10.3923\/jms.2003.66.86","DOI":"10.3923\/jms.2003.66.86"},{"issue":"2","key":"9970_CR71","doi-asserted-by":"publisher","first-page":"148","DOI":"10.21608\/bfpc.2019.101875","volume":"57","author":"M Elrefay","year":"2019","unstructured":"Elrefay M, Elfiky A, Sayed R, Zaki H (2019) Snake venom, bee venom and their components exert an anti-cancer effect by triggering apoptosis and cell cycle arrest in prostate cancer. Bull Fac Pharm 57(2):148\u2013156. https:\/\/doi.org\/10.21608\/bfpc.2019.101875","journal-title":"Bull Fac Pharm"},{"issue":"1","key":"9970_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.15430\/jcp.2017.22.1.40","volume":"22","author":"H Akef","year":"2017","unstructured":"Akef H, Kotb N, Abo-Elmatty D, Salem S (2017) Anti-proliferative effects of Androctonus Amoreuxi scorpion and Cerastes cerastes snake venoms on human prostate cancer cells. J Cancer Prev 22(1):40\u201346. https:\/\/doi.org\/10.15430\/jcp.2017.22.1.40","journal-title":"J Cancer Prev"},{"issue":"22","key":"9970_CR73","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.3390\/molecules26227057","volume":"26","author":"MI Abdelglil","year":"2021","unstructured":"Abdelglil MI, Abdallah SO, El-Desouky MA, Alfaifi MY, Elbehairi SEI, Mohamed AF (2021) Evaluation of the anticancer potential of crude, irradiated Cerastes cerastes snake venom and Propolis ethanolic extract & related biological alterations. Molecules 26(22):7057. https:\/\/doi.org\/10.3390\/molecules26227057","journal-title":"Molecules"},{"issue":"3","key":"9970_CR74","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s10495-012-0787-1","volume":"18","author":"G Badr","year":"2013","unstructured":"Badr G, Al-Sadoon MK, Rabah DM, SayedD (2013) Snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles induce apoptosis and growth arrest in human prostate cancer cells. Apoptosis 18(3):300\u2013314. https:\/\/doi.org\/10.1007\/s10495-012-0787-1","journal-title":"Apoptosis"},{"key":"9970_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2013.06.018","volume":"65","author":"G Badr","year":"2013","unstructured":"Badr G, Al-Sadoon MK, Rabah DM (2013) Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models. Free Radic Biol Med 65:175\u2013189. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.06.018","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"9970_CR76","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1080\/15569543.2020.1826970","volume":"40","author":"S \u0130lhan","year":"2021","unstructured":"\u0130lhan S, \u00c7i\u00e7ek K, Tok CV, Atmaca H (2021) Profiling of apoptosis-associated proteins in human prostate cancer cells in response to Montivipera bulgardaghica albizona venom by protein array. Toxin Rev 40(4):1040\u20131047. https:\/\/doi.org\/10.1080\/15569543.2020.1826970","journal-title":"Toxin Rev"},{"key":"9970_CR77","doi-asserted-by":"publisher","unstructured":"Harvey AL (2013) Snake Peptides. In Handbook of Biologically Active Peptides, 2nd edition. Elsevier, pp 451\u2013460. https:\/\/doi.org\/10.1016\/B978-0-12-385095-9.00062-2","DOI":"10.1016\/B978-0-12-385095-9.00062-2"},{"issue":"9","key":"9970_CR78","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.trecan.2017.07.004","volume":"3","author":"R Mahadevappa","year":"2017","unstructured":"Mahadevappa R, Ma R, Kwok HF (2017) Venom peptides: improving specificity in cancer therapy. Trends Cancer 3(9):611\u2013614. https:\/\/doi.org\/10.1016\/j.trecan.2017.07.004","journal-title":"Trends Cancer"},{"issue":"2","key":"9970_CR79","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/1535-7163.mct-06-0328","volume":"6","author":"DJ Son","year":"2007","unstructured":"Son DJ, Park MH, Chae SJ, Moon SO et al (2007) Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor \u03baB. Mol Cancer Ther 6(2):675\u2013683. https:\/\/doi.org\/10.1158\/1535-7163.mct-06-0328","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"9970_CR80","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/0959-8049(95)00648-6","volume":"32","author":"MW Swaim","year":"1996","unstructured":"Swaim MW, Chiang HS, Huang TF (1996) Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin. Eur J Cancer 32(4):715\u2013721. https:\/\/doi.org\/10.1016\/0959-8049(95)00648-6","journal-title":"Eur J Cancer"},{"key":"9970_CR81","doi-asserted-by":"publisher","first-page":"107746","DOI":"10.1016\/j.toxicon.2024.107746","volume":"243","author":"JV Alberghini-dos-Santos","year":"2024","unstructured":"Alberghini-dos-Santos JV, Sanchez CA, Bordon KDCF, Pucca MB, Antunes LMG, Arantes EC, de Oliveira IS (2024) Effects of crotamine in human prostate cancer cell line. Toxicon 243:107746. https:\/\/doi.org\/10.1016\/j.toxicon.2024.107746","journal-title":"Toxicon"},{"issue":"11","key":"9970_CR82","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.7150\/jca.15309","volume":"7","author":"J Chaisakul","year":"2016","unstructured":"Chaisakul J, Hodgson WC, Kuruppu S, Prasongsook N (2016) Effects of animal venoms and toxins on hallmarks of cancer. J Cancer 7(11):1571\u20131578. https:\/\/doi.org\/10.7150\/jca.15309","journal-title":"J Cancer"},{"key":"9970_CR83","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.toxicon.2012.05.001","volume":"60","author":"C Guo","year":"2012","unstructured":"Guo C, Liu S, Yao Y, Zhang Q, Sun MZ (2012) Past decade study of snake venom L-amino acid oxidase. Toxicon 60:302\u2013311","journal-title":"Toxicon"},{"issue":"6","key":"9970_CR84","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7150\/ijms.8096","volume":"11","author":"ML Lee","year":"2014","unstructured":"Lee ML, Fung SY, Chung I, Pailoor J, Cheah SH, Tan NH (2014) King cobra (ophiophagus hannah) venom L-amino acid oxidase induces apoptosis in PC-3 cells and suppresses PC-3 solid tumor growth in a tumor xenograft mouse model. Int J Med Sci 11(6):593\u2013601. https:\/\/doi.org\/10.7150\/ijms.8096","journal-title":"Int J Med Sci"},{"key":"9970_CR85","doi-asserted-by":"publisher","first-page":"110785","DOI":"10.1016\/j.cellsig.2023.110785","volume":"109","author":"L Polloni","year":"2023","unstructured":"Polloni L, Costa TR, Morais LP, Borges BC et al (2023) Oxidative stress induced by Pollonein-LAAO, a new L-amino acid oxidase from Bothrops moojeni venom, prompts prostate tumor spheroid cell death and impairs the cellular invasion process in vitro. Cell Signal 109:110785. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110785","journal-title":"Cell Signal"},{"key":"9970_CR86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.toxicon.2017.09.012","volume":"139","author":"KK Tan","year":"2017","unstructured":"Tan KK, Ler SG, Gunaratne J, Bay BH, Ponnampalam G (2017) In vitro cytotoxicity of L-amino acid oxidase from the venom of Crotalus mitchellii pyrrhus. Toxicon 139:20\u201330. https:\/\/doi.org\/10.1016\/j.toxicon.2017.09.012","journal-title":"Toxicon"},{"key":"9970_CR87","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jep.2017.11.026","volume":"213","author":"W Lu","year":"2018","unstructured":"Lu W, Hu L, Yang J, Sun X et al (2018) Isolation and pharmacological characterization of a new cytotoxic L-amino acid oxidase from Bungarus multicinctus snake venom. J Ethnopharmacol 213:311\u2013320. https:\/\/doi.org\/10.1016\/j.jep.2017.11.026","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"9970_CR88","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.toxicon.2012.03.023","volume":"60","author":"M Samel","year":"2012","unstructured":"Samel M, Trummal K, Siigur E, Siigur J (2012) Effect of HUVEC apoptosis inducing proteinase from Vipera lebetina venom (VLAIP) on viability of cancer cells and on platelet aggregation. Toxicon 60(4):648\u2013655. https:\/\/doi.org\/10.1016\/j.toxicon.2012.03.023","journal-title":"Toxicon"},{"issue":"19","key":"9970_CR89","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0025-7753(04)74656-4","volume":"123","author":"VG Villarrubia","year":"2004","unstructured":"Villarrubia VG, Costa LA, D\u00edez RA (2004) Secreted phospholipases A2 (sPLA2): friends or foes? Actors of the antibacterial and anti-HIV resistance? Med Clin 123(19):749\u2013757. https:\/\/doi.org\/10.1016\/S0025-7753(04)74656-4","journal-title":"Med Clin"},{"issue":"1","key":"9970_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.24267\/23897325.194","volume":"4","author":"J Quintana","year":"2017","unstructured":"Quintana J, Avila I, Ceballos J, Vargas L, Estrada S (2017) Efecto citot\u00f3xico de fosfolipasas A2 del veneno de Crotalus durissus cumanensis de Colombia. Rev Invest Salud 4(1):17\u201336. https:\/\/doi.org\/10.24267\/23897325.194","journal-title":"Rev Invest Salud"},{"key":"9970_CR91","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.ijbiomac.2021.05.114","volume":"182","author":"MPC Naves","year":"2021","unstructured":"Naves MPC, de Morais CR, de Freitas V, Ribeiro DL et al (2021) Mutagenic and genotoxic activities of phospholipase A2 Bothropstoxin-I from Bothrops jararacussu in Drosophila melanogaster and human cell lines. Int J Biol Macromol 182:1602\u20131610. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.05.114","journal-title":"Int J Biol Macromol"},{"key":"9970_CR92","doi-asserted-by":"publisher","first-page":"e8055","DOI":"10.7717\/peerj.8055","volume":"7","author":"TV Tran","year":"2019","unstructured":"Tran TV, Siniavin AE, Hoang AN, Le MTT et al (2019) Phospholipase A2 from krait Bungarus fasciatus venom induces human cancer cell death in vitro. PeerJ 7:e8055. https:\/\/doi.org\/10.7717\/peerj.8055","journal-title":"PeerJ"},{"issue":"9","key":"9970_CR93","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.biocel.2013.06.009","volume":"45","author":"C Marcinkiewicz","year":"2013","unstructured":"Marcinkiewicz C (2013) Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol 45(9):1974\u20131986. https:\/\/doi.org\/10.1016\/j.biocel.2013.06.009","journal-title":"Int J Biochem Cell Biol"},{"key":"9970_CR94","unstructured":"M\u00e1rquez P (2021) Aislamiento y pruebas de actividad biol\u00f3gica de desintegrinas de Croatalus polystictus. Undergraduate Dissertation, Universidad de las Am\u00e9ricas Puebla-M\u00e9xico"},{"issue":"12","key":"9970_CR95","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/pros.21173","volume":"70","author":"E Lin","year":"2010","unstructured":"Lin E, Wang Q, Swenson S, Jadvar H et al (2010) The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo. Prostate 70(12):1359\u20131370. https:\/\/doi.org\/10.1002\/pros.21173","journal-title":"Prostate"},{"key":"9970_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9845-6_10","volume-title":"Snake and spider toxins. Methods in Molecular Biology","author":"SD Swenson","year":"2020","unstructured":"Swenson SD, Silva-Hirschberg C, Markland FS (2020) Methods for evaluation of a snake venom-derived disintegrin in animal models of Human Cancer. In: Priel A (ed) Snake and spider toxins. Methods in Molecular Biology, vol 2068. Humana, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4939-9845-6_10"},{"issue":"5","key":"9970_CR97","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.toxicon.2005.01.013","volume":"45","author":"RS Yang","year":"2005","unstructured":"Yang RS, Tang CH, Chuang WJ, Huang TH, Peng HC, Huang TF, Fu WM (2005) Inhibition of tumor formation by snake venom disintegrin. Toxicon 45(5):661\u2013669. https:\/\/doi.org\/10.1016\/j.toxicon.2005.01.013","journal-title":"Toxicon"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09970-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09970-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09970-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:50:07Z","timestamp":1738731007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09970-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9970"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09970-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article contains no studies with human participants or animals performed by authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1153"}}